Quality of Life of Post-Thyroidectomy Patients Before and After the Radioactive Iodine Ablation Therapy: A Quasi-Experimental Study
DOI:
https://doi.org/10.3329/jopsom.v44i2.89235Keywords:
Quality of life, Thyroid cancer, radioactive iodine ablationAbstract
Background: Postoperative radioactive iodine (RAI) ablation is used in thyroid cancer patients to eliminate residual malignant tissue to reduce recurrence risk and improve quality of life (QoL). This study aimed to evaluate the changes in QoL among thyroid cancer patients before and after RAI therapy following thyroidectomy.
Methods: A quasi-experimental study was conducted from August 2022 to July 2025, including 218 thyroid cancer patients post thyroidectomy at Institute of Nuclear Medicine, Dhaka. Data were collected through face-to-face interview using a validated, pre-tested, semi-structured questionnaire at one and three months after surgery (pre-RAI and post-RAI), during which QoL was assessed using the FACT-G scale. Informed consent was obtained from all participant addressing proper ethical issues.
Results: The study demonstrated a predominance of female participants (64.2%), with a mean age of 44.14 ± 15.41 years; approximately half of the respondents were aged below 40 years. The majority had attained education up to the SSC level (37.6%), was married (72.9%), and belonged to lower-income groups (74.3%), with housewives comprising the largest occupational category (34.9%). Males had slightly higher median QoL scores than females (97 vs. 96; p < 0.05) post-RAI therapy. Younger age, higher educational attainment, marital status, and employment were associated to higher median improvements in QoL scores. (p < 0.05). Significant increase in median overall QoL scores from 48 to 96 (p < 0.01), with notable improvements in the physical (7 to 25), social (17 to 24), emotional (7 to 23), and functional (16 to 25) domains. Additionally, older age and marital status was significantly associated to lower QoL (OR = 0.100, p < 0.05) while higher educational attainment was strongly associated with improved QoL (OR = 1507.114).
Conclusion: Radioactive iodine ablation significantly improves multiple Quality of life dimensions in thyroid cancer survivors underscoring its broad therapeutic value.
JOPSOM 2025; 44(2): 13-21
Downloads
11
12
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Col AKM Farhad Hossain, Sayada Fatema Khatun, Ifrat Jahan Mousome, Md Ziaul Islam

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Authors who publish in the Journal of Preventive and Social Medicine (JOPSOM) agree to the following terms that:
- Authors retain copyright and grant the Journal of Preventive and Social Medicine (JOPSOM) the right of first publication of the work.

Articles in the Journal of Preventive and Social Medicine (JOPSOM) are Open Access articles published under the Creative Commons CC BY-NC License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license permits Share — copy and redistribute the material in any medium or format and Adapt — remix, transform, and build upon the material.